期刊文献+

肿瘤PET乏氧显像的临床研究进展 被引量:1

Clinical research progress of PET imaging in tumor hypoxia
原文传递
导出
摘要 乏氧是实体瘤的常见现象,与肿瘤的增殖、恶性进展、放化疗抵抗、耐药性、治疗失败、不良预后密切相关。目前较多的相关研究集中于应用影像学、核医学方法检测肿瘤乏氧区域方面。该文对肿瘤乏氧微环境的检测及多种PET显像剂应用于肿瘤乏氧显像的研究进展进行综述。 Hypoxia is a common phenomenon of solid tumor,which is closely related to the malignant proliferation,tumor progression,radiotherapy and chemotherapy resistance,treatment failure,and poor prognosis.At present,many researches focus on the application of medical imaging and nuclear medicine methods in detecting the hypoxic areas of tumors.This article focuses on the detection of hypoxia microenvironment and the application of PET tracers in tumor hypoxia imaging.
作者 马苑 付秀华 王立红 顾岩 Ma Yuan;Fu Xiuhua;Wang Lihong;Gu Yan(Department of Cadre Health Care,Inner Mongolia People′s Hospital,Hohhot 010017,China;Department of Respiratory and Critical Care Medicine,Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China)
出处 《中华核医学与分子影像杂志》 CAS CSCD 北大核心 2021年第9期562-565,共4页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 内蒙古自治区自然科学基金(2018LH08026)。
关键词 肿瘤 缺氧 正电子发射断层显像术 发展趋势 Neoplasms Anoxia Positron-emission tomography Trends
  • 相关文献

参考文献2

二级参考文献33

  • 1MengX, SunX, MuD, et al. Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 82(2):960-966. DOI:10.1016/j.ijrobp.2010.10.064.
  • 2YuJ, LiX, XingL, et al. Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study[J]. Int J Radiat Oncol Biol Phys, 2009, 75(5):1468-1474. DOI:10.1016/j.ijrobp.2009.01.019.
  • 3KayaniI, GrovesAM. 18F-fluorodeoxyglucose PET/CT in cancer imaging[J]. Clin Med (Lond), 2006, 6(3):240-244. DOI:10.7861/clinmedicine.6-3-240.
  • 4PlathowC, WeberWA. Tumor cell metabolism imaging[J]. J Nucl Med, 2008, 49Suppl 2:43S-63S. DOI:10.2967/jnumed.107.045930.
  • 5JiangL, TuY, ShiH, et al. PET probes beyond 18F-FDG[J]. J Biomed Res, 2014, 28(6):435-446. DOI:10.7555/JBR.28.20130196.
  • 6KhanN, OriuchiN, NinomiyaH, et al. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET[J]. Ann Nucl Med, 2004, 18(5):409-417.
  • 7DeGradoTR, ColemanRE, WangS, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer[J]. Cancer Res, 2001, 61(1):110-117.
  • 8LiuS. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging[J]. Mol Pharm, 2006, 3(5):472-487. DOI:10.1021/mp060049x.
  • 9WeiYC, HuX, GaoY, et al. Noninvasive evaluation of metabolic tumor volume in lewis lung carcinoma tumor-bearing C57BL/6 mice with micro-PET and the radiotracers 18F-Alfatide and 18F-FDG: a comparative analysis[J]. PLoS One, 2015, 10(9):e0136195. DOI:10.1371/journal.pone.0136195.
  • 10ZhangH, LiuN, GaoS, et al. Can a novel 18F-ALF-NOTA-PRGD2 PET/CT predict the treatment sensitivity of concurrent chemoradiotherapy in patients with newly diagnosed glioblastoma? [J/OL]. J Nucl Med, 2015[2016-01-06]. http://jnm.snmjournals.org/content/early/2015/10/28/jnumed.115.165514.short?rss=1. DOI: 10.2967/jnumed.115.165514. [Epub ahead of print].

共引文献17

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部